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 Background: The use of rigid nasal endoscopy is one of the common methods to 
investigate anomalies and pathologies of nasal cavities in the patients with sinonasal 
symptoms. 
Purpose: To identify the effect of whole pomegranate extract on pain relief during nasal 
endoscopy. 
Methods: Adults candidate for rigid nasal endoscopy were enrolled from January 2015 to 
April 2015 in Loghman hospital. The patients were randomized in a double-blinded fashion, 
to receive two solutions; whole pomegranate extract(WPE)  and shrinkage solution (SS) that 
was consisted of 5cc lidocaine 2% and 5cc phenylephrin 0.5 %. The principle outcomes 
were severity of pain and mucosal appearance during nasal endoscopy. 
Results: A total of 41 patients (mean age: 40.05±12.92) were studied. There were no 
significant differences in severity of pain and mucosal appearance between both groups. 
Conclusion: A new point in modern medicine is using traditional medicine as a 
complementary arm.  The natural elements can be sometimes a good alternative. The 
pomegranate extract probably has constrictive effects and can be an alternative for 
vasoconstrictor drugs.   There is a need for stronger research in this field. 
Cite this article as: Ahmady Roozbahany N, NikooSeresht F, MohammadKhani M, Oroei M. Evaluation of Whole 
Pomegranate Extract as Decongestant for Preparation before Diagnostic Rigid Nasal Endoscopy: a Double Blind 
Randomized Clinical Trial. 2016; 2(2): 47-50. 
INTRODUCTION
Since the invention of the rigid nasal 
endoscopy by Hopkins and Storz in 1959, this 
procedure has become one of the most 
common diagnostic tools in the domain of 
ENT specialty and nowadays this is a part of 
the routine examination in many patients with 
sinonasal symptoms rather in offices or in 
hospitals (1). 
Using an endoscope, anomalies and 
pathologies of nasal cavities from nostrils till 
nasopharynx can be observed and the 
physician can also take samples if necessary. 
Most of the patients complain of pain, 
discomfort and sense of foreign body in the 
nose during nasal endoscopy. On the other 
hand, mucosal congestion and hyperemia can 
cause bleeding during the procedure and it can 
also decrease the visual capabilities of the 
physician during the procedure(1, 2)  
Plants have been utilized as medicine for 
thousands of years. There are many books from 
ancient civilizations of Iran, India and China 
about the effect of herbal medicine in treating 
many diseases. World Health Organization 
(WHO) named 252 kinds of essential drugs 
that 11% of them are made directly from plants 
or they have the herbal origin. Nowadays, there 
is a tendency to use herbal medications instead 
of synthetic drugs because synthetic 
medications are not accessible around the globe 
and in popular belief, herbal medications do 
not have the side effect of synthetic 
medications and the over use of them is 
believed to be virtually harmless (3-6). 
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Pomegranate is a botanical name for 
Punicagranatum. It is a fruit-bearing 
deciduous shrub or small tree. In Iranian 
herbal and traditional medicine, pomegranate 
has a constrictor effect. This effect is less in 
pomegranate juice and is higher in 
pomegranate skin (7). 
In this study, we used whole pomegranate 
extract, which contains seeds, juice and skin 
of pomegranate as decongestant material 
before rigid nasal endoscopy. 
 
PATIENTS and METHODS 
In this double blind randomized clinical trial, 
41 patients were evaluated in Loghman 
Hakim hospital, Shahid Beheshti University 
of Medical Sciences, Tehran, Iran. All of the 
patients referred to otolaryngology clinic who 
were candidate for rigid nasal endoscopy from 
January 2015 to April 2015 regardless of 
symptoms, entered the study. Two solutions 
were prepared and labeled with codes A and 
B. Material A was 10 cc of whole 
pomegranate extractand (WPE) and material 
B was consisted of 5cc lidocaine 2% and 5cc 
phenylephrin 0.5 % which is called shrinkage 
solution (SS). For making WPE we used 3 
kilograms of pomegranate, we sliced them and 
then boiled them with 1000cc of water for 2 
hours in a closed container, then we used this 
material as whole pomegranate extract.  In 
each solution, we put 10 shrinkage bondage 
that was 10×1cm vibril cotton bondage. All 
the materials and bandages were made every 
day and they kept in a closed container in 
environment temperature. Randomly in one 
nasal cavity we put shrinkage material A and 
we put material B on the other side. 
 An ear nose throat resident performed all of 
the procedures of preparing the shrinkage 
material and putting the cotton pad in the 
nasal cavities of patients under the middle 
turbinate. All of interventions were assured by 
the investigator's direct observation. 
The patient and endoscopist were blind about 
the side of the application of each material. 
After five minutes the shrinkage bondages 
were brought out of nasal cavities and patient 
was referred to endoscopy room. After 
finishing the endoscopy, the patient and the 
physician filled a questionnaire about the pain 
and discomfort through endoscopy and the 
mucosal appearance of nasal cavity. The 
patient pain was evaluated in a scaled 0-10 by 
visual analog scale, which score 10 represents 
"severe" and score 0 the opposite. The 
severity of these variables were categorized  
to  four level (score 0: no pain , score1-3: mild 
, 4-6 : moderate and 7-10 : sever). 
 All the data was gathered and analyzed with 
SPSS for windows version 20 (SPSS Inc., 
Chicago, IL).  The continuous variable was 
described to mean and standard deviation. The 
qualitative variables were reported frequency 
and percentage. The variables were 
reclassified dichotomous and analyzed using 
McNemar's test. Statistical significant was 
defined less than 0.05. A written informed 
consent was obtained from the patients prior 
to the enrollment. The medical ethics 
committee of Shahid Beheshti University of 




In that period of time 41 patients entered the 
study that 23 of them were male (56%) and 18 
were female (44%). The age of patients 
ranged between 16 and 75 years and mean age 
of patients was 40.05 ± 12.92 years. Twenty-
one (51.2%) and 20 patients (48.8%) reported 
no pain during nasal endoscopy in shrinkage 
solution and whole pomegranate extract 
groups respectively. There was no significant 
difference in severity of pain between the two 
groups (table 1). 
Only one patient had mucous hyperemia in 
WPE group. The appearance of nasal mucosa 
following application of WPE and SS were 
similar (p-value: 1.00). 
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Severity of pain; n (%) 
No pain 21(51.2) 20(48.8) 
0.25 Mild 17(41.5) 15(36.6) Moderate 3(7.3) 2(4.9) 
Sever 0(0.0) 4(9.8) 
Mucosal Appearance; n (%) 
Normal 4(9.8) 3(7.3) 
1.00 Pale 37(90.2) 37(90.2) 
Hyperemic 0(0.0) 1(2.4) 
 
DISCUSSION 
According to Iranian traditional medicine 
opinion, pomegranate has the constrictor effect 
and this effect is more in its skin rather than 
seeds and juice (8-11). 
Nasal endoscopy has a very important role in 
approach to nasosinusal symptoms, but most of 
the patients have pain and discomfort due to 
contact of the endoscope lens with the nasal 
mocusa. Cophenylcaine (phenylephrin 
+lidocain) is usually used as decongestant and 
anesthetic before the procedure but the bitter 
taste of lidocaine is not tolerable in some 
people, thus, making the endoscopy more 
annoying (1, 2, 12, 13). 
Walsche et al. examined 33 patients and used 
cophenylcaine spray (containing lignocaine 5% 
(50mg/ml) and phenylephrine 0.5% (5mg/ml)) 
in one nasal cavity and cocaine 10%+adrenalin 
in the other side before rigid nasal endoscopy. 
They analyzed the pain and discomfort that the 
patients tolerated and there was no significant 
difference between two groups (14). 
Douglas et al. examined 30 patients in two 
visits. They used cophenylcaine spray for one 
group before rigid nasal endoscopy in the first 
visit and lidocaine 2% spray in the second visit. 
In the other group, they did the opposite, 
lidocaine 2% in the first nasal endoscopy and 
cophenylcaine spray in the second visit. 
Subsequently, they gathered the data of pain 
that patients tolerated by visual analogue scale 
(VAS) of these two groups and there were no 
significant differences between these two 
groups (1, 15).  
Pothier et al. in his study suggested that patients 
who applied the cophenylcaine spray 10 
minutes before nasal endoscopy suffer less pain 
than patients using this spray one minute before 
nasal endoscopy (1, 16). 
Most  authors suggest that using decongestant 
material alone for preparing the patient before 
nasal endoscopy has the equal effect of 
decongestant and decreasing the pain by using 
the decongestant and anesthetic material 
together. Moreover, it also has no bitter taste of 
lidocaine (1). 
Pomegranate originated in the region of 
modern-day Iran, and has been cultivated since 
ancient times throughout the Mediterranean 
region and northern India. The most abundant 
phytochemicals in pomegranate juice are 
polyphenols, including the hydrolyzab. Tannins 
called ellagitannins forms when ellagic acid 
and/or gallic acid binds with a carbohydrate to 
form pomegranate ellagitannins, also known as 
punicalagins. Compared to the pulp, the 
inedible pomegranate peel contains as much as 
three times the total amount of polyphenols, 
including condensed tannins, catechins, 
gallocatechins and prodelphinidins. A 100-gram 
serving of pomegranate seeds provides 12% of 
the daily value (DV) for vitamin C, 16% DV 
for vitamin K and 10% DV for folate. 
Pomegranate seed oil contains punicic acid 
(65.3%), palmitic acid (4.8%), stearic acid 
(2.3%), oleic acid (6.3%), and linoleic acid 
(6.6%)(17). 
By reviewing the Iranian herbal medicine we 
found that pomegranate has been used as a 
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constrictor for many years and have proven 
effects.  
By analyzing the data we found that there were 
no significant difference between standard 
material and pomegranate extract in reducing 
the pain during endoscopy and the mucosal 
appearance in both methods were the same. 
Therefore, pomegranate extract could be used 
as decongestant material in nasal mucosa. 
 
CONCLUSION 
Pomegranate extract has proven to have 
constrictive effects and has been used for 
many years. In otolaryngology we may need 
decongestants in many diagnostic and 
therapeutic procedures. Therefore, this study is 
the first step of using the pomegranate as 
mucosal decongestant and maybe in the future 
it can be used as an alternative for 
vasoconstrictor or decongestant drugs. 
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